SOX10 and neoplasm: Efforts to therapeutically target SOX10 have been challenging due to the relative inaccessibility of targeted therapies to transcription factors and specific complexities associated with loss of SOX10 activity, which may promote tumor cell invasion and metastasis under certain circumstances.